$213.00 Original price was: $213.00.$181.00Current price is: $181.00.
Molecular Formula: C₁₄H₂₂CuN₆O₄ + C₆₂H₉₈N₁₆O₂₂ + C₂₁₂H₃₅₀N₅₆O₇₈S
GLOW – 70mg is a synthetic peptide blend composed of GHK-Cu, BPC-157, and TB-500 designed for stability in peptide research environments.
Each batch is analytically verified for purity using chromatographic methods and accompanied by batch-specific Certificate of Analysis (COA) documentation.
19 in stock
19 in stock
GLOW – 70mg is a peptide blend composed of several structurally distinct peptides commonly examined in laboratory research environments. The formulation includes GHK-Cu, BPC-157, and TB-500, each representing short amino acid chains that researchers frequently investigate in controlled experimental settings.
Peptides are short chains of amino acids that function as signaling molecules within biological systems. Within laboratory environments, peptide compounds are often examined to better understand molecular signaling processes, receptor interaction pathways, and peptide-mediated cellular communication.
Multi-peptide blends such as GLOW combine several peptide structures into a single formulation, allowing researchers to examine peptide interactions and molecular stability characteristics within controlled research environments.
Peptide Name: GLOW Peptide Blend
Quantity: 70mg
Composition:
• GHK-Cu – 50mg
• BPC-157 – 10mg
• TB-500 – 10mg
Sequence Length:
• GHK-Cu – 3 amino acids
• BPC-157 – 15 amino acids
• TB-500 – 17 amino acids
Purity: ≥99%
Appearance: Lyophilized blue powder
Each batch of the GLOW peptide blend undergoes analytical verification to confirm compound identity and purity. Analytical procedures commonly include high-performance liquid chromatography (HPLC) and other analytical techniques used to evaluate peptide composition and structural integrity.
Verification procedures evaluate:
• peptide purity profile
• chromatographic retention time
• batch consistency
• molecular identity confirmation
Analytical data corresponding to each production batch is documented through a Certificate of Analysis (COA).
A Certificate of Analysis provides documentation associated with a specific production lot. These documents contain analytical data confirming compound purity and laboratory testing methodology.
COA documentation commonly includes:
• batch identification number
• purity percentage
• chromatographic testing results
• analytical method
• laboratory verification data
Researchers reference COA documentation to maintain traceability and consistency within experimental workflows.
The peptides contained within the GLOW formulation are produced using solid-phase peptide synthesis (SPPS), a process widely used for assembling peptide sequences through sequential amino acid coupling.
The synthesis process typically includes:
sequential amino acid assembly
purification using chromatographic separation
analytical confirmation of molecular identity
lyophilization to maintain compound stability
Following purification, the peptides are freeze-dried to preserve structural integrity during storage and transportation.
Lyophilized peptides should be stored under controlled conditions to maintain stability.
Recommended handling considerations include:
• storing in a cool dry environment
• minimizing exposure to moisture and heat
• avoiding repeated freeze-thaw cycles after reconstitution
Proper storage helps maintain compound integrity during laboratory research.
Each vial is labeled with batch identification to support traceability for laboratory research applications.
Researchers examining peptide signaling pathways often investigate related peptide compounds including:
GHK-Cu – 50mg
BPC-157 – 5mg
BPC-157 – 10mg
TB-500 – 10mg
These peptide compounds are frequently studied within laboratory environments investigating molecular signaling pathways and peptide interaction mechanisms.
Scientific literature describing peptide signaling mechanisms and experimental peptide research is available through peer-reviewed research databases.
This product is supplied for laboratory research use only.
Not intended for human or veterinary use.
Products distributed by Aevitas Research are intended exclusively for laboratory research purposes and must be handled by qualified professionals in controlled research environments.
Verified compounds. Ready to ship.
© Aevitas Research 2026. All rights reserved
The statements made on this website have not been evaluated by the U.S. Food and Drug Administration, the products offered are not intended to diagnose, treat, cure, or prevent any disease, Aevitas Research is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, and all products are sold strictly for research purposes only and are not for human or animal consumption.